Up to one-third of Americans have been affected by data stolen through the Change Healthcare cyberattack; research highlights potential cognitive and psychiatric benefits of semaglutide; over 40 Iowa hospitals have ended their labor and delivery services.
Change Healthcare Cyberattack Fuels Widespread Fraud Risks
The Change Healthcare cyberattack, which compromised the personal data of millions, is now expected to cause identity theft and various forms of fraud, according to Axios. Attorneys general from states including Indiana, Massachusetts, and Pennsylvania are urging affected individuals to monitor their credit and be vigilant against suspicious activities. Despite the significant breach, UnitedHealth Group has faced criticism for delayed notifications to consumers and inadequate cybersecurity measures.
Ozempic Linked to Reduced Cognitive Problems in Patients With Diabetes
A new study finds semaglutide (Ozempic; Novo Nordisk) use is associated with a reduced risk of cognitive problems and nicotine dependence in patients who have diabetes, according to The Hill. Analyzing over 100,000 US patient records, the study revealed that semaglutide does not increase the risk of neurological or psychiatric conditions compared with other antidiabetic medications. Although the findings are promising, the observational nature of the study calls for further investigation to confirm these results and understand the underlying mechanisms.
Decline in Rural Birth Rates Forces Iowa Hospitals to Close Obstetrics Units
Rural Iowa is experiencing a significant decline in birth rates, leading to the closure of labor and delivery units in more than 40 hospitals since 2000, according to Kaiser Health News. This trend, reflective of a nationwide issue, leaves many rural areas without local birthing services, posing challenges for expectant mothers. Despite the closures, Oskaloosa’s Mahaska Health hospital has bucked the trend by expanding its obstetrics services and attracting new specialists, offering a glimmer of hope for rural health care.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen